Satellos Bioscience Inc.
MSCLF
$0.4284
$0.01934.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.76% | -19.71% | 9.19% | -149.04% | -44.42% |
| Total Depreciation and Amortization | -100.00% | -50.00% | 473.33% | 0.00% | 185.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.23% | 496.89% | -123.88% | 602.52% | -78.21% |
| Change in Net Operating Assets | 370.34% | -703.88% | -190.67% | -17.25% | 88.49% |
| Cash from Operations | -13.21% | -33.42% | -201.13% | -7.64% | -48.27% |
| Capital Expenditure | 0.00% | -- | 100.00% | 100.00% | 42.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 325.45% | -- | 35.54% | -- | -- |
| Cash from Investing | 325.94% | -- | 35.54% | 173,180.00% | 38,350.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11,500.00% | -- | 1,515.71% | -- | -99.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 408.49% | -- | -- |
| Cash from Financing | 11,500.00% | -- | 8,667.32% | 110.76% | -99.97% |
| Foreign Exchange rate Adjustments | 296.75% | 102.59% | 126.13% | -97.30% | 71.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 318.19% | -5.07% | 249.91% | 399.43% | -107.41% |